Page last updated: 2024-08-26

alphaxalone and rocuronium

alphaxalone has been researched along with rocuronium in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's3 (100.00)2.80

Authors

AuthorsStudies
Chen, IY; Itami, T; Kato, K; Sano, T; Tamogi, H; Wei, Y; Yamashita, K1
Chen, IY; Daimaruya, N; Itami, T; Sano, T; Sugita, C; Wei, Y; Yamashita, K2

Trials

2 trial(s) available for alphaxalone and rocuronium

ArticleYear
Effects of sevoflurane, propofol or alfaxalone on neuromuscular blockade produced by a single intravenous bolus of rocuronium in dogs.
    Veterinary anaesthesia and analgesia, 2022, Volume: 49, Issue:1

    Topics: Androstanols; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Dogs; Female; Male; Methyl Ethers; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Pregnanediones; Propofol; Prospective Studies; Rocuronium; Sevoflurane

2022
ED
    Veterinary anaesthesia and analgesia, 2023, Volume: 50, Issue:3

    Topics: Androstanols; Anesthesia; Animals; Dogs; Female; Male; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Prospective Studies; Rocuronium

2023

Other Studies

1 other study(ies) available for alphaxalone and rocuronium

ArticleYear
Sugammadex for reversal of rocuronium-induced neuromuscular blockade during alfaxalone anesthesia in dogs.
    Veterinary anaesthesia and analgesia, 2023, Volume: 50, Issue:6

    Topics: Anesthesia; Anesthetics; Animals; Cross-Over Studies; Dogs; Female; Male; Neuromuscular Blockade; Neuromuscular Nondepolarizing Agents; Prospective Studies; Rocuronium; Sugammadex

2023